Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir

BACKGROUND: HIV infection and antiretroviral treatment are associated with changes in lipid levels, insulin resistance and risk of cardiovascular disease (CVD). We investigated these changes in the first 96 weeks of treatment with low-dose stavudine or tenofovir regimens. METHODS: This is a secondar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Alinda G., Chersich, Matthew F., Klipstein-Grobusch, Kerstin, Zuithoff, Peter, Moorhouse, Michelle A., Lalla-Edward, Samanta T., Kambugu, Andrew, Kumarasamy, N., Grobbee, Diederick E., Barth, Roos E., Venter, Willem D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295103/
https://www.ncbi.nlm.nih.gov/pubmed/30547820
http://dx.doi.org/10.1186/s12977-018-0460-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295103/
https://www.ncbi.nlm.nih.gov/pubmed/30547820
http://dx.doi.org/10.1186/s12977-018-0460-z

Ejemplares similares